Verastem Common Stock Shares Outstanding from 2010 to 2026
| VSTM Stock | USD 6.22 0.06 0.96% |
Common Stock Shares Outstanding | First Reported 2011-03-31 | Previous Quarter 74 M | Current Value 73.2 M | Quarterly Volatility 16 M |
Check Verastem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Verastem's main balance sheet or income statement drivers, such as Other Operating Expenses of 78.5 M, Research Development of 98.2 M or Total Operating Expenses of 75.7 M, as well as many indicators such as Price To Sales Ratio of 32.08, Dividend Yield of 0.0 or Days Sales Outstanding of 7.98. Verastem financial statements analysis is a perfect complement when working with Verastem Valuation or Volatility modules.
Verastem | Common Stock Shares Outstanding | Build AI portfolio with Verastem Stock |
Evaluating Verastem's Common Stock Shares Outstanding across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Verastem's fundamental strength.
Latest Verastem's Common Stock Shares Outstanding Growth Pattern
Below is the plot of the Common Stock Shares Outstanding of Verastem over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. Verastem's Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Verastem's overall financial position and show how it may be relating to other accounts over time.
| Common Stock Shares Outstanding | 10 Years Trend |
|
Common Stock Shares Outstanding |
| Timeline |
Verastem Common Stock Shares Outstanding Regression Statistics
| Arithmetic Mean | 12,591,813 | |
| Geometric Mean | 5,536,348 | |
| Coefficient Of Variation | 115.12 | |
| Mean Deviation | 11,443,181 | |
| Median | 5,776,749 | |
| Standard Deviation | 14,495,461 | |
| Sample Variance | 210.1T | |
| Range | 43M | |
| R-Value | 0.89 | |
| Mean Square Error | 47.9T | |
| R-Squared | 0.79 | |
| Slope | 2,545,677 | |
| Total Sum of Squares | 3361.9T |
Verastem Common Stock Shares Outstanding History
About Verastem Financial Statements
Verastem investors utilize fundamental indicators, such as Common Stock Shares Outstanding, to predict how Verastem Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 41.1 M | 43.1 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Verastem Correlation against competitors. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Will Biotechnology sector continue expanding? Could Verastem diversify its offerings? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Verastem data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (4.28) | Revenue Per Share | Quarterly Revenue Growth (0.79) | Return On Assets | Return On Equity |
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Verastem's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.